Hasil Pencarian - Heinrich Roder
- Menampilkan 1 - 14 hasil dari 14
-
1
-
2
Explaining multivariate molecular diagnostic tests via Shapley values oleh Joanna Roder, Laura Maguire, Robert Georgantas, Heinrich Roder
Diterbitkan 2021-07-01Dapatkan teks lengkap
Artikel -
3
-
4
Exact Shapley values for local and model-true explanations of decision tree ensembles oleh Thomas W. Campbell, Heinrich Roder, Robert W. Georgantas III, Joanna Roder
Diterbitkan 2022-09-01Dapatkan teks lengkap
Artikel -
5
Robust identification of molecular phenotypes using semi-supervised learning oleh Heinrich Roder, Carlos Oliveira, Lelia Net, Benjamin Linstid, Maxim Tsypin, Joanna Roder
Diterbitkan 2019-05-01Dapatkan teks lengkap
Artikel -
6
-
7
-
8
-
9
831 Exact Shapley values for explaining complex machine learning based molecular tests of checkpoint inhibitors: potential utility for patients, physicians, and translational resea... oleh Joanna Roder, Heinrich Roder, Minu Srivastava, Wei Zou, Mark McCleland, David Shames, Laura Maguire, Lelia Net, Thomas Campbell, Robert Georgantas
Diterbitkan 2021-11-01Artikel -
10
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations oleh Paolo A. Ascierto, Mariaelena Capone, Antonio M. Grimaldi, Domenico Mallardo, Ester Simeone, Gabriele Madonna, Heinrich Roder, Krista Meyer, Senait Asmellash, Carlos Oliveira, Joanna Roder, Julia Grigorieva
Diterbitkan 2019-03-01Dapatkan teks lengkap
Artikel -
11
26 Validation of the Primary Immune Response (PIR) test in advanced non-small cell lung cancer (NSCLC): blinded retrospective analyses from the POPLAR and OAK trials oleh Joanna Roder, Heinrich Roder, Senait Asmellash, Minu Srivastava, Wei Zou, Mark McCleland, David Shames, Laura Maguire, Steven Rightmyer, Patrick Norman, Lelia Net, Thomas Campbell, Robert Georgantas
Diterbitkan 2021-11-01Artikel -
12
28 Predictions of outcomes and benefit of immune checkpoint inhibitor treatment in NSCLC require information on both tumor and host biology oleh Joanna Roder, Heinrich Roder, Senait Asmellash, Minu Srivastava, Wei Zou, Mark McCleland, David Shames, Laura Maguire, Steven Rightmyer, Patrick Norman, Lelia Net, Thomas Campbell, Robert Georgantas
Diterbitkan 2021-11-01Artikel -
13
Molecular and translational biology of the blood-based VeriStrat® proteomic test used in cancer immunotherapy treatment guidance oleh Matthew A. Koc, Timothy Aaron Wiles, Daniel C. Weinhold, Steven Rightmyer, Amanda L. Weaver, Colin T. McDowell, Joanna Roder, Senait Asmellash, Gary A. Pestano, Heinrich Roder, Robert W. Georgantas III
Diterbitkan 2023-11-01Dapatkan teks lengkap
Artikel -
14
Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lu... oleh Alessandra I. G. Buma, Berber Piet, Rob ter Heine, Michel M. van den Heuvel, Paul Brinkman, Daan van den Broek, Sjaak Burgers, Francesco Ciompi, Simona M. Cristescu, Bram van Ginneken, Katrien Grünberg, Lizza Hendriks, Jeroen Hiltermann, Firdaus Mohamed Housein, Alwin Huitema, Jakko van Inge, Colin Jacobs, Hans Koenen, Marjolijn Ligtenberg, Anke H. Maitland-van der Zee, Vincent van der Noort, Mathias Prokop, Valesca Rètel, Heinrich Roder, Huub van Rossum, Ruben Smeets, Thomas Würdinger
Diterbitkan 2023-11-01Dapatkan teks lengkap
Artikel